US20080194467A1 - Cancer treatment methods using cadherin ...,https://www.google.com/patents/US20080194467
WO2008039525A2 - Cadherin antagonists in combination with ...,http://www.google.com/patents/WO2008039525A2?cl=en
WO2016196895A1 - Methods amd compositions for promoting ...,https://www.google.com/patents/WO2016196895A1?cl=en
"WO1994014960A2 - Protocadherin, their autibodies and uses ...",https://www.google.com/patents/WO1994014960A2?cl=en23
US20080095764A1 - Use of genetically-and epigenetically-altered ...,https://www.google.com/patents/US20080095764
EP2242769A2 - Cadherin-11 ec1 domain antagonists for treating ...,https://www.google.com/patents/EP2242769A2?cl=un
WO2010109066A1 - Dysfunction of the mitochondrial respiratory ...,https://www.google.com/patents/WO2010109066A1?cl=en
EP1532277A2 - Single nucleotide polymorphisms sensitively ...,https://www.google.com/patents/EP1532277A2
EP1192268A2 - Nucleic acid binding of multi-zinc finger ...,https://www.google.com/patents/EP1192268A2
WO2000023587A2 - Gene therapy of alzheimer's disease by ...,https://www.google.com/patents/WO2000023587A2
